Compounded formulations, paired with genetic guidance, enable precision medicine at accessible pricingan advantage unavailable with brand-name alternatives relying solely on standard dosing protocols
GLP-1 receptor agonists : Semaglutide (Wegovy) is licensed for weight management and may be prescribed through specialist weight management services for eligible patients according to NICE TA875, which specifies BMI thresholds and treatment duration limits
224 : 8386 Rosenthal RE, Williams R, Bogaert YE, Getson PR, Fiskum G
Key administration details for compounded tirzepatide: Subcutaneous injection, once weekly Rotate injection sites: abdomen, thigh, upper arm Store reconstituted solution in refrigerator Refrigeration is required after reconstitution Shelf life in fridge : typically 28-30 days after reconstitution Room temperature stability is limited, see tirzepatide room temperature guidelines Retatrutide administration Retatrutide is currently available only as a research compound in lyophilized powder form
generics may drop to 1,000-2,000
In the STEP-4 trial (N=803), patients who continued semaglutide 2.4 mg maintained their weight loss, while those who switched to placebo regained an average of 6.9% body weight over 48 weeks, underscoring that this is a chronic therapy rather than a short course